The Center for Precision Medicine for High-risk Pediatric Cancer Frontier Program builds upon ongoing precision medicine efforts across CHOP departments to define and expand treatment options.
CHOP's NoT Bleeding Program will conduct clinical trials to develop the next generation of therapeutics for hemophilia A, B, and other bleeding disorders.
Led by Dr. Elizabeth Foglia, MD, MSCE, the 2022 Frontier Program will aim to inform guidelines for resuscitating newborns that have congenital anomalies.